{"count": 7, "results": [{"_id": "35359831", "pmid": 35359831, "pmcid": "PMC8961328", "title": "Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice", "journal": "Front Pharmacol", "authors": ["Brooks SD", "Smith RL", "Moreira AS", "Ackerman HC"], "date": "2022-03-10T00:00:00Z", "doi": "10.3389/fphar.2022.798349", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "798349", "score": 50274.633, "text_hl": "A sex difference was observed: kidney @GENE_ACE2 @GENE_70008 @@@ACE2@@@ levels were higher in male than in female @SPECIES_10090 @@@mice@@@ (p < 0.0001). Oral @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ increases @GENE_ACE2 @GENE_70008 @@@ACE2@@@, the cellular receptor for @SPECIES_2697049 @@@SARS-CoV-2@@@, in tissues that are relevant to the transmission and pathogenesis of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@. ", "citations": {"NLM": "Brooks SD, Smith RL, Moreira AS, Ackerman HC. Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice Front Pharmacol. 2022;13():798349. PMID: 35359831", "BibTeX": "@article{35359831, title={Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice}, author={Brooks SD and Smith RL and Moreira AS and Ackerman HC}, journal={Front Pharmacol}, volume={13}, pages={798349}}"}}, {"_id": "34769093", "pmid": 34769093, "pmcid": "PMC8584039", "title": "Whey-Derived Peptides at the Heart of the COVID-19 Pandemic", "journal": "Int J Mol Sci", "authors": ["Chamata Y", "Jackson KG", "Watson KA", "Jauregi P"], "date": "2021-10-28T00:00:00Z", "doi": "10.3390/ijms222111662", "meta_date_publication": "2021 Oct 28", "meta_volume": "22", "meta_issue": "21", "meta_pages": "", "score": 50252.504, "text_hl": "This dual activity distinguishes these @GENE_AP2B1 @GENE_163 @@@ACE@@@ inhibitory peptides from synthetic drugs, such as @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@Captopril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ which were not shown to inhibit @GENE_ACE2 @GENE_59272 @@@ACE2@@@ activity, and may represent a potential strategy in the treatment of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@.", "citations": {"NLM": "Chamata Y, Jackson KG, Watson KA, Jauregi P. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic Int J Mol Sci. 2021 Oct 28;22(21):. PMID: 34769093", "BibTeX": "@article{34769093, title={Whey-Derived Peptides at the Heart of the COVID-19 Pandemic}, author={Chamata Y and Jackson KG and Watson KA and Jauregi P}, journal={Int J Mol Sci}, volume={22}, number={21}}"}}, {"_id": "34017819", "pmid": 34017819, "pmcid": "PMC8129187", "title": "Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor", "journal": "Front Chem", "authors": ["Al-Karmalawy AA", "Dahab MA", "Metwaly AM", "Elhady SS", "Elkaeed EB", "Eissa IH", "Darwish KM"], "date": "2021-05-04T00:00:00Z", "doi": "10.3389/fchem.2021.661230", "meta_date_publication": "2021", "meta_volume": "9", "meta_issue": "", "meta_pages": "661230", "score": 50251.54, "text_hl": "@<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@Severe Acute Respiratory Syndrome Coronavirus 2@@@ (@<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@SARS-CoV-2@@@) or @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ was the name that the WHO designated for the disease caused by the @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@novel coronavirus@@@ (Coronaviridae Study Group of the International Committee on Taxonomy of Viruses,). ", "citations": {"NLM": "Al-Karmalawy AA, Dahab MA, Metwaly AM, Elhady SS, Elkaeed EB, Eissa IH, Darwish KM. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor Front Chem. 2021;9():661230. PMID: 34017819", "BibTeX": "@article{34017819, title={Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor}, author={Al-Karmalawy AA and Dahab MA and Metwaly AM and Elhady SS and Elkaeed EB and Eissa IH and Darwish KM}, journal={Front Chem}, volume={9}, pages={661230}}"}}, {"_id": "35534886", "pmid": 35534886, "title": "A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles.", "journal": "J Cosmet Dermatol", "authors": ["Kalantari Y", "Aryanian Z", "Mirahmadi SM", "Alilou S", "Hatami P", "Goodarzi A"], "date": "2022-07-01T00:00:00Z", "doi": "10.1111/jocd.15071", "meta_date_publication": "2022 Jul", "meta_volume": "21", "meta_issue": "7", "meta_pages": "", "score": 50242.473, "text_hl": "A systematic review on @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ vaccination and cosmetic filler reactions: A focus on case studies and original articles.", "citations": {"NLM": "Kalantari Y, Aryanian Z, Mirahmadi SM, Alilou S, Hatami P, Goodarzi A. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles. J Cosmet Dermatol. 2022 Jul;21(7):. PMID: 35534886", "BibTeX": "@article{35534886, title={A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles.}, author={Kalantari Y and Aryanian Z and Mirahmadi SM and Alilou S and Hatami P and Goodarzi A}, journal={J Cosmet Dermatol}, volume={21}, number={7}}"}}, {"_id": "32896463", "pmid": 32896463, "pmcid": "PMC7546192", "title": "Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group ", "journal": "Neurologia (Engl Ed)", "authors": ["Morollón N", "Belvís R", "De Dios A", "Pagès N", "González-Oria C", "Latorre G", "Santos-Lasaosa S"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.nrl.2020.07.007", "meta_date_publication": "2020 Nov-Dec", "meta_volume": "35", "meta_issue": "9", "meta_pages": "628-632", "score": 50240.63, "text_hl": "We also recommend evaluating other treatment options in @SPECIES_9606 @@@patients@@@ already taking @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ for @DISEASE_Migraine_Disorders @DISEASE_MESH:D008881 @@@migraine@@@ and presenting risk factors for severe @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ (Table 1 ).", "citations": {"NLM": "Morollón N, Belvís R, De Dios A, Pagès N, González-Oria C, Latorre G, Santos-Lasaosa S. Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group  Neurologia (Engl Ed). 2020 Nov-Dec;35(9):628-632. PMID: 32896463", "BibTeX": "@article{32896463, title={Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group }, author={Morollón N and Belvís R and De Dios A and Pagès N and González-Oria C and Latorre G and Santos-Lasaosa S}, journal={Neurologia (Engl Ed)}, volume={35}, number={9}, pages={628-632}}"}}, {"_id": "38620330", "pmid": 38620330, "title": "[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].", "journal": "Neurologia", "authors": ["Morollón N", "Belvís R", "De Dios A", "Pagès N", "González-Oria C", "Latorre G", "Santos-Lasaosa S"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.nrl.2020.07.007", "meta_date_publication": "2020 Nov-Dec", "meta_volume": "35", "meta_issue": "9", "meta_pages": "628-632", "score": 50240.195, "text_hl": "Material and methods: We collected information on the opinions of scientific societies and medicines agencies (American, European, and Spanish) to clarify doubts regarding the use of drugs such as @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@, @CHEMICAL_Ibuprofen @CHEMICAL_MESH:D007052 @@@ibuprofen@@@, corticosteroids, @CHEMICAL_Carbamazepine @CHEMICAL_MESH:D002220 @@@carbamazepine@@@, and monoclonal antibodies targeting the calcitonin gene-related peptide in the context of the @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ pandemic. ", "citations": {"NLM": "Morollón N, Belvís R, De Dios A, Pagès N, González-Oria C, Latorre G, Santos-Lasaosa S. [Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group]. Neurologia. 2020 Nov-Dec;35(9):628-632. PMID: 38620330", "BibTeX": "@article{38620330, title={[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].}, author={Morollón N and Belvís R and De Dios A and Pagès N and González-Oria C and Latorre G and Santos-Lasaosa S}, journal={Neurologia}, volume={35}, number={9}, pages={628-632}}"}}, {"_id": "32752951", "pmid": 32752951, "title": "Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.", "journal": "J Biomol Struct Dyn", "authors": ["Khelfaoui H", "Harkati D", "Saleh BA"], "date": "2021-11-01T00:00:00Z", "doi": "10.1080/07391102.2020.1803967", "meta_date_publication": "2021 Nov", "meta_volume": "39", "meta_issue": "18", "meta_pages": "7246-7262", "score": 50238.074, "text_hl": "The reactivity, molecular docking and molecular dynamics were performed for two receptors @GENE_ACE2 @GENE_59272 @@@ACE2@@@ and [@SPECIES_2697049 @@@SARS-CoV-2@@@/@GENE_ACE2 @GENE_59272 @@@ACE2@@@] complex receptor in two active sites to find a ligand, which may inhibit @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@. The results obtained from this study showed that @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@Ramipril@@@, @CHEMICAL_delapril @CHEMICAL_MESH:C047759 @@@Delapril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ could bind with @GENE_ACE2 @GENE_59272 @@@ACE2@@@ receptor and [@SPECIES_2697049 @@@SARS-CoV-2@@@/@GENE_ACE2 @GENE_59272 @@@ACE2@@@] complex better than @CHEMICAL_Chloroquine @CHEMICAL_MESH:D002738 @@@chloroquine@@@ and @CHEMICAL_Hydroxychloroquine @CHEMICAL_MESH:D006886 @@@hydroxychloroquine@@@. ", "citations": {"NLM": "Khelfaoui H, Harkati D, Saleh BA. Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2. J Biomol Struct Dyn. 2021 Nov;39(18):7246-7262. PMID: 32752951", "BibTeX": "@article{32752951, title={Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.}, author={Khelfaoui H and Harkati D and Saleh BA}, journal={J Biomol Struct Dyn}, volume={39}, number={18}, pages={7246-7262}}"}}]}